PROSONIX

Welcome to the Brand page for “PROSONIX”, which is offered here for Medicines for human purposes for the treatment of respiratory diseases and disorders; drugs for medical purposes for the treatment of respiratory diseases and disorders; medicaments formulated for pulmonary delivery for the treatment of respiratory diseases and disorders; medicaments for inhalation for the treatment of respiratory diseases and disorders; medicaments for chronic obstructive pulmonary disease; medicaments for asthma; none of the foregoing for use in the treatment of gastro-intestinal diseases or disorders;scientific and technological services, scientific research and analysis and new product research and design relating thereto in the field of pharmaceuticals; pharmaceutical development services; pharmaceutical development utilising ultrasound; preparation and/or formulation, development of pharmaceuticals; product development consultancy services in relation to formulations for inhalation and/or pulmonary delivery; scientific research consultancy services on the application of ultrasound to chemical processes; scientific research consultancy services on the application of ultrasound to crystallisation processes;.

Its status is currently believed to be active. Its class is unavailable. “PROSONIX” is believed to be currently owned by “Circassia Limited”.